Neonates, or newborns, are particularly vulnerable to diseases and disorders due to their immature organs and immune systems. Traditional drug delivery methods often fall short, either due to inefficacy or potential toxicity. Nanoparticle-based delivery systems can offer several advantages: - Targeted Delivery: Nanoparticles can be engineered to target specific cells or tissues, minimizing side effects and enhancing the efficacy of the drug. - Controlled Release: These systems can be designed to release the drug in a controlled manner, ensuring sustained therapeutic levels over time. - Crossing Biological Barriers: Nanoparticles can cross biological barriers like the blood-brain barrier, which is crucial for treating neurological conditions in neonates.
